Expertisebureau IMA
0447.319.161 · rovalta.com · 24/09/2026
ACTIVE
Expertisebureau IMA
Financial year 2025 · Closed on 31/03/2025
Net result
2,3 k €
+114,3 %over 1 yearRevenue
24,9 k €
-14,2 %over 1 yearEquity
213,8 k €
+1,1 %over 1 yearOverview
Identity
Source · BCE/KBOExpertisebureau IMA is a Public limited company incorporated in 1992. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Balen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0447.319.161
- Incorporation
- 04/05/1992
- Legal form
- Public limited company
- Registered office
- Kruisblokken 25-4
2491 Balen · FlandreSee on map - Contributed capital
- 65 507,00 €
- Latest accounts
- 31/03/2025
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 19 filingsTrend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 24,9 k € | -14.2% | 29 k € | -25.7% | 39 k € | -13.0% | 44,9 k € | +19.3% | 37,6 k € |
| EBITDA | 11,2 k € | +12.1% | 10 k € | -21.3% | 12,6 k € | -35.6% | 19,6 k € | -6.4% | 21 k € |
| Operating result | 4,6 k € | +38.8% | 3,3 k € | -44.9% | 6 k € | -53.8% | 13 k € | +159% | 5 k € |
| Net result | 2,3 k € | +114% | 1,1 k € | -49.3% | 2,1 k € | -70.9% | 7,2 k € | +376% | 1,5 k € |
| Balance sheet | |||||||||
| Equity | 213,8 k € | +1.1% | 211,5 k € | +0.5% | 210,5 k € | +1.0% | 208,4 k € | +3.6% | 201,2 k € |
| Total assets | 219,3 k € | -4.2% | 228,9 k € | +0.5% | 227,7 k € | -2.9% | 234,6 k € | +6.0% | 221,5 k € |
| Cash | 17,6 k € | -30.9% | 25,5 k € | +7.7% | 23,7 k € | +187% | 8,2 k € | +252% | 2,3 k € |
| Debts | 2,6 k € | -77.1% | 11,2 k € | -24.6% | 14,8 k € | -32.4% | 21,9 k € | +32.4% | 16,6 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/03/20252 active · 3 ended
Active mandates
Active
Active
Ended mandates
Annemieke Geenen
EndedJohan Geenen
EndedPeter Geenen
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/04/2024 | 01/04/2023 | 01/04/2022 | 01/04/2021 | 01/04/2020 | 01/04/2019 |
| Closing of the financial year | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 | 31/03/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/09/2025 | 23/10/2024 | 13/10/2023 | 12/10/2022 | 22/10/2021 | 14/10/2020 |
| General meeting | 26/09/2025 | 27/09/2024 | 27/09/2023 | 28/09/2022 | 29/09/2021 | 23/09/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 19 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/03/2025 | 26/09/2025 | 29/09/2025 | Dutch | |
| Micro model | 31/03/2024 | 27/09/2024 | 23/10/2024 | Dutch | |
| Micro model | 31/03/2023 | 27/09/2023 | 13/10/2023 | Dutch | |
| Micro model | 31/03/2022 | 28/09/2022 | 12/10/2022 | Dutch | |
| Micro model | 31/03/2021 | 29/09/2021 | 22/10/2021 | Dutch | |
| Micro model | 31/03/2020 | 23/09/2020 | 14/10/2020 | Dutch | |
| Micro model | 31/03/2019 | 25/09/2019 | 12/10/2019 | Dutch | |
| Micro model | 31/03/2018 | 19/09/2018 | 01/10/2018 | Dutch | |
| Micro model | 31/03/2017 | 20/09/2017 | 10/10/2017 | Dutch | |
| Abridged model | 31/03/2016 | 21/09/2016 | 27/09/2016 | Dutch | |
| Abridged model | 31/03/2015 | 23/09/2015 | 29/09/2015 | Dutch | |
| Abridged model | 31/03/2014 | 29/09/2014 | 16/10/2014 | Dutch | |
| Abridged model | 31/03/2013 | 25/09/2013 | 14/10/2013 | Dutch | |
| Abridged model | 31/03/2012 | 25/09/2012 | 02/10/2012 | Dutch | |
| Abridged model | 31/03/2011 | 23/09/2011 | 11/10/2011 | Dutch | |
| Abridged model | 31/03/2010 | 24/09/2010 | 18/10/2010 | Dutch | |
| Abridged model | 31/03/2009 | 25/09/2009 | 31/10/2009 | Dutch | |
| Abridged model | 31/03/2008 | 29/09/2008 | 27/10/2008 | Dutch | |
| Abridged model | 31/03/2007 | 26/09/2007 | 29/10/2007 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/03/20252 active · 3 ended
Active mandates
Active
Active
Ended mandates
Annemieke Geenen
EndedJohan Geenen
EndedPeter Geenen
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20252,3 k €↑
- 2024Annual accounts 20241,1 k €↓
- 2023Annual accounts 20232,1 k €↓
- 2022Annual accounts 20227,2 k €↑
- 2021Annual accounts 20211,5 k €↑
- 2020Annual accounts 2020890 €↓
- 2019Annual accounts 20196,9 k €↑
- 2018Annual accounts 2018-8,2 k €↓
- 2017Annual accounts 201724 k €↑
- 2016Annual accounts 201610,1 k €↑
- 2015Annual accounts 20159 k €↑
- 2014Annual accounts 20148,2 k €↓
- 2013Annual accounts 201319,8 k €↑
- 2012Annual accounts 201212,1 k €↑
- 2011Annual accounts 20111,2 k €↓
- 2010Annual accounts 20107,7 k €↑
- 2009Annual accounts 20095,6 k €
- 04/05/1992IncorporationPublic limited company